Company profile for Azurity Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We focus on the needs of special patient populations, such as children and the elderly, for whom customized doses and user-friendly formulations tailored to their needs do not exist. Azurity’s growing portfolio of FDA-approved drugs eliminates the need for compounding and gives these patients an easy-to-consume medication that meets the highest standards of safety and efficacy.In some cases, when an FDA-approved formulation ...
We focus on the needs of special patient populations, such as children and the elderly, for whom customized doses and user-friendly formulations tailored to their needs do not exist. Azurity’s growing portfolio of FDA-approved drugs eliminates the need for compounding and gives these patients an easy-to-consume medication that meets the highest standards of safety and efficacy.In some cases, when an FDA-approved formulation is not yet available and compounding is required, our convenient FIRST® Unit-of-Use Kits allow pharmacists to provide patients with a product manufactured with high quality and standardization.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
8 Cabot Road, Suite 2000, Woburn, MA 01801
Telephone
Telephone
1-800-461-7449
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220258

FDA
24 Oct 2025

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220256

FDA
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/02/3160235/0/en/George-Medicines-strengthens-global-commercialization-strategy-for-GMRx2-with-exclusive-Biolab-Farmac%C3%AAutica-licensing-agreement-in-Brazil.html

GLOBENEWSWIRE
02 Oct 2025

https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-inc-announces-the-availability-of-brynovin-sitagliptin-the-first-and-only-oral-liquid-sitagliptin-302519017.html

PR NEWSWIRE
31 Jul 2025

https://www.globenewswire.com/news-release/2025/07/21/3118577/0/en/George-Medicines-signs-exclusive-licensing-agreement-with-Azurity-Pharmaceuticals-to-commercialize-WIDAPLIK-telmisartan-amlodipine-and-indapamide-tablets-in-the-US.html

GLOBENEWSWIRE
21 Jul 2025

https://www.fiercepharma.com/marketing/whos-next-pharma-marketing

FIERCE PHARMA
18 Jul 2025

ABOUT THIS PAGE

Contact Silvergate Pharmaceuticals and get a quotation

Silvergate Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Glucagon bulk offered by Silvergate Pharmaceuticals

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty